Eculizumab 300 Mg Injection 300mg/30ml Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 300mg/30ml
Reference Brands: Bkemv (USA), Soliris (EU/LATAM)
Category: Orphan Drugs
Eculizumab injection is used to treat a type of blood disease called paroxysmal nocturnal hemoglobinuria (PNH). This medicine helps reduce red blood cell destruction or breakdown (hemolysis) in patients with PNH.
Product Description:
Eculizumab-aeeb is a highly targeted biologic medicine used in the treatment of rare complement-mediated disorders, particularly paroxysmal nocturnal hemoglobinuria (PNH). PNH is a rare genetic condition characterized by intermittent destruction of red blood cells due to uncontrolled activation of the complement system. The underlying cause of PNH is a deficiency of CD59, a natural complement inhibitor that normally protects red blood cells from the membrane attack complex (MAC). Without this protective mechanism, red blood cells are vulnerable to complement-mediated lysis, leading to anemia, fatigue, and other complications.
Eculizumab-aeeb works by specifically inhibiting complement protein C5, effectively preventing the formation of the MAC and reducing the destruction of red blood cells. This targeted mechanism helps control hemolysis, improves patient quality of life, and reduces the risk of complications associated with PNH. As a recombinant monoclonal antibody, Eculizumab-aeeb is produced using advanced biotechnology and is available in regulated markets across the United States, Europe, and other international regions. Its clinical effectiveness has made it a cornerstone therapy for patients living with this rare and life-impacting condition.
Eculizumab 300 Mg Injection — third party manufacturing & bulk supply
Eculizumab 300 Mg Injection 300mg/30ml is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Eculizumab 300 Mg Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Eculizumab 300 Mg Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Eculizumab-aeeb is used for the treatment of rare and serious complement-mediated disorders. It is indicated for conditions such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). It works by inhibiting the complement protein C5, which helps prevent the destruction of red blood cells and reduces damage caused by uncontrolled complement system activation.
Eculizumab-aeeb is a recombinant monoclonal antibody produced using advanced biotechnology in genetically engineered cell lines. It is designed to specifically target and block complement component C5.
A commonly known trade name associated with this biosimilar is Bkemv.
Eculizumab-aeeb is manufactured by Amgen and distributed in regulated markets where biosimilar approvals are granted.
The generic name is Eculizumab-aeeb.
One of the well-known brand names is Bkemv. The reference product in this category is Soliris.
Eculizumab-aeeb is manufactured in regulated biopharmaceutical production facilities in countries such as the United States and other regions that follow strict biologics manufacturing and quality standards.
Related Products
Pasireotide Diaspartate
Strength:
0.3 mg/mL, 0.6 mg/mL, 1.2 mg/mL, 10 mg, 20 mg, 30 mg
Form: Injection
Reference Brands: Signifor (USA/EU)
View Details
Sepiapterin
Strength:
1000 mg, 250 mg
Form: Tablets / oral powder
Reference Brands: Sephience (USA/EU)
View Details
Glycerol Phenylbutyrate
Strength:
1.1 g/mL
Form: Oral Solution
Reference Brands: Ravicti (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
